INOVIQ in the News

    INOVIQ (ASX:IIQ) and University of Queensland to develop ovarian cancer test  
    ASX Health Stocks: UK FSA welcomes Cann’s CBD capsules onto its approved list  
    INOVIQ wants to beat cancer to the punch with world-first diagnostic solutions  
    INOVIQ (ASX:IIQ) partners with ResearchDx to develop SubB2M-based cancer tests in the US  
    Bard1 Awarded Biomedical Translation Bridge Funding to Develop Breast Cancer Tests  
    BARD1 Life Sciences (ASX:BD1) Presentation, FNN Online Investor Event, October 2021  
    INOVIQ reveals its SubB2M technology can detect all stages of breast cancer from a blood sample, 100% specificity and 95% sensitivity.  
    INOVIQ share price doubles following positive announcement on ovarian cancer detection technology.  
    Media release: The Australian Government is backing several Australian research projects aimed at finding breakthrough treatments, diagnostics and a vaccine in the fight against COVID-19.  
    AusBiotech: Government announces support for COVID-19 research projects  
    INOVIQ Life Sciences (ASX:BD1) receives European patent validation for cancer tests  
    INOVIQ Limited was represented at the AACR Annual Meeting 2020 by CSO Dr Irmgard Irminger-Finger who gave an invited oral presentation on 24 April 2020.  
    Proactive Investors covers INOVIQ breast cancer test announcement today INOVIQ develops world’s first blood test for early detection of breast cancer  
    Article published by SmallCaps today INOVIQ develops world first blood test for breast cancer detection  
    Article published by StocksDigital in nextBIOTECH Top Results: INOVIQ Continues to Boost its Ovarian Cancer Detection Studies  
    Article published by finfeed INOVIQ inks critical deal to develop autoantibody test  
    Interview of INOVIQ CEO Dr Leearne Hinch by Proactive Investors INOVIQ approaching “important milestone” on path to commercialisation  
    Article published by Proactive Investors INOVIQ signs agreement to develop custom research assay  
    INOVIQ announces positive results from ovarian cancer test  
    Article published by SMALL CAPS on INOVIQ’s Ovarian Cancer Detection Study  
    Interview of INOVIQ LSL Executive Director and CSO Dr Irmgard Irminger-Finger by Startwerk “BARD1AG SA: The real fight against lung cancer”